Summary This study is on 2 groups of leprosy pa tients using the Mitsuda lepromin test. The first group of 37 patients received O·
The Mitsuda lepromin reaction is an important indicator of the ability of the host to mount a cell mediated immune response to Mycobacterium leprae. The lepromin test was described by Hayashi I and Mitsuda.2 The standard Mitsuda lepromin reaction is read after 3--4 weeks. A reading of more than 5 mm is taken as positive. The preparation of lepromin has been standardized by WHO.3 Studies4• s have suggested that the lepromin test was one of the most useful indicators to determine the risk of relapse in patients treated with Dapsone monotherapy.
It is becoming increasingly difficult to obtain human lepromatous leprosy tissue to prepare Mitsuda lepromin. However, lepromin prepared from armadillo tissue is now becoming more easily available.6 If lepromin is to be used as a criterion to determine the treatment and release from control of patients, then armadillo lepromin will have to be used. This study compares the Mitsuda lepromin reactions using armadillo (Lepromin-A, 40 M bacilli per ml) and human lepromin (Lepromin-H, 40 and 100 M bacilli per ml).
Materials and methods
This present study is on 2 groups ofleprosy patients of all classifications. The first group of 37 patients received both human and armadillo lepromin in concentra tions of 40 M bacilli per ml. The second group of 60 patients were given 40 M bacilli per ml of Lepromin-A and 100 M bacilli per ml of Lepromin-H.
Three of the larger clinic sub-centres of the Schieffelin Leprosy Research and Training Centre in Karigiri, Gudiyatham Taluk were chosen fo r the study. This area has been previously described.7 Patients of all classifications were randomly chosen for the study.
Human lepromin (Lepromin-H) injections of 0· 1 ml and armadillo lepromin (Lepromin-A) were given intradermally. The injections were randomized to one or other arm by use of calculator generated random numbers. Each patient received both human and armadillo lepromin, either in the left or right arm. The lepromin readings were taken 4 weeks later by a minimum of2, up to a maximum of 6 observers according to availability. The observers were all paramedical staff or medical officers belonging to the leprosy control unit who had had previous experience and training in the reading of the lepromin test.
Neither the patients nor the observers knew which arm had been given Lepromin-A or Lepromin-H. One arm was read at a time and the readings noted by the chief investigator or the senior paramedical worker who assisted in the study. The observers were not allowed to compare the reading of both arms before recording their results.
Lepromin-H containing 40 M bacilli per ml was obtained from the National Institute of Medical Research Laboratories, Mill Hill, London, UK. Lepromin-A of the same strength, 40 M bacilli per ml, was obtained from WHO H eadquarters, Geneva. Lepromin-H of concentration 100 M bacilli per ml, was prepared at the Laboratories of the Schieffelin Leprosy Research and Training Centre, according to standard protocol suggested by the World Health Organization.3
Results

STUDY 1
The age, sex and type of leprosy in the 37 patients who received 0· 1 ml of human and armadillo lepromin of the concentration 40 M bacilli per ml is given in Table  I . Their average lepromin readings according to age and type are given in Table 2 . The average Mitsuda lepromin readings using the armadillo lepromin (Lepro min-A) was consistently higher than the human lepromin (Lepromin-H) readings (Table 2) .
The results were analysed by the technique of Nested 2-way analysis of variance,S using the individual readings. There was no significant difference in reading between the sexes or ages_ The Lepromin-A readings however were statistically significantly higher (P< O-OOI) than the Lepromin-H readings. The overall average lepromin reading using Lepromin-A was 4·7 mm and Lepromin H2 -1 mm.
STUDY 2
A similar method of analysis as fo r Study I was used. Table I gives the age, sex and type of leprosy in the 60 patients who received 0· 1 ml of Lepromin-H of concentration 100 M bacilli per ml and 0· 1 ml of Lepromin-A, concentration of 40 M bacilli per m!. The average lepromin readings of the 60 patients, by age and type are given in Table 2 . This table shows that the lepromin readings using Lepromin-A and -H were very similar. There was no significant difference in the readings when the ages and sexes were compa red_ When the lepromin readings using Lepromin-A and -H were analysed as in Study 1, there was no significant difference in the readings. The overall average Mitsuda lepromin reading using Lepromin-A was 6·9 mm and the average lepromin reading using Lepromin-H was 6-3 mm.
Discussion
One study9 using similar concentrations of Lepromin-A (175 M bacilli per ml) and Lepromin-H (160 M bacilli per ml), reported an exaggerated response in patients receiving Lepromin-A. Using the same concentration of Lepromin-A and -H (160 M bacilli per ml) another studylO also obtained an exaggerated result in individuals receiving Lepromin-A .
Three double blind trials II were carried out to determine the late reactivity of 103 leprosy patients and unaffected persons to different concentrations of human and armadillo lepromin. They suggested that a concentration of armadillo lepromin of I M bacilli per ml would be best fo r routine work in comparison with the human lepromin. A studl reviewing the work of comparative studies of human and armadillo lepromin, states that several workers have shown concordance of Mitsuda reaction evoked by Lepromin-A and Lepromin-H. A studyl2 of 41 leprosy patients using Lepromin-H in concentration of 80 M bacilli per ml and Lepromin-A 40 M bacilli per ml, fo und that the Mitsuda lepromin reading was significantly higher using Lepromin-H.
In the present study the Mitsuda lepromin readings using 40 M bacilli per ml of Lepromin-A and -H, were significantly different. The average reading of Lepromin-H and -A were 4·7 and 2' 1, respectively. However, the lepromin readings using Lepromin-A, 40 M bacilli ml and Lepromin-H 100 M bacilli per ml were similar (6·90 versus 6·3 mm), and not statistically different.
This study suggests that for obtaining comparative readings in human and armadillo lepromin, a concentration of 40 M bacilli per ml, of Lepromin-A compa res fa vourably with 100 M bacilli per ml of Lepromin-H. Thus, for routine use of the lepromin test, the above strengths are recommended.
Previous studies at Karigiri4 indicated that lepromin reaction is one ' of the most important criteria fo r determining the risk of relapse in paucibacillary leprosy. It was also suggested that lepromin positivity could be used as a criterion to determine chemotherapeutic regimens. The important constraint however was the unavailability of Lepromin-H. This study provides rationale for the possible substitution of Lepromin-A in the concentration of 40 M bacilli per ml, instead of Lepromin-H concentration 100 M bacilli per m!. Field studies are planned to evaluate this possibility.
